A 2024 double-blind randomized trial of 156 participants with early Parkinsons disease found that participants receiving a GLP-1 drug, lixisenatide, showed no progression of motor symptoms, compared to a measurable worsening on standard motor scales in the placebo group
Germany is one of the prominent consumers of glutathione resin, owing to the significant presence of research and development facilities of global pharmaceutical and biochemical companies
2011), which constitutes a higher burden than simply taking a supplement pill
Powder Food Supplement Containing Hydrolyzed Collagen and Hyaluronic Acid with approval number 014215-04.08.2022
This is why research is also exploring natural ways of stimulating the body's natural secretion of GLP-1 , alongside a suitable lifestyle
Chlorinated C1 and C2 hydrocarbons in the marine environment